| scholarly article | Q13442814 |
| P953 | full work available at URL | http://www.jimmunol.org/cgi/content/abstract/155/10/5003 |
| P698 | PubMed publication ID | 7594507 |
| P2093 | author name string | W. J. Karpus | |
| S. L. Kunkel | |||
| S. D. Miller | |||
| R. M. Strieter | |||
| B. L. McRae | |||
| N. W. Lukacs | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| experimental autoimmune encephalomyelitis | Q494066 | ||
| autoimmune disease | Q8084905 | ||
| P304 | page(s) | 5003-5010 | |
| P577 | publication date | 1995-11-01 | |
| 1995-11-15 | |||
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis | |
| P478 | volume | 155 |
| Q37708089 | A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease |
| Q33793526 | A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination |
| Q33782634 | Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis |
| Q33252011 | An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians |
| Q33693006 | Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease |
| Q35126948 | C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis |
| Q35764380 | C-C chemokines differentially alter interleukin-4 production from lymphocytes |
| Q35786870 | C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system |
| Q34931963 | CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response |
| Q27346578 | CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction |
| Q36309229 | CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis |
| Q45710477 | CCL2 transgene expression in the central nervous system directs diffuse infiltration of CD45(high)CD11b(+) monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease |
| Q34417523 | CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function |
| Q35788387 | CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. |
| Q35113362 | CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function |
| Q38702121 | CCR5 blockade for neuroinflammatory diseases--beyond control of HIV. |
| Q36384816 | CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions |
| Q37832444 | CD46 plasticity and its inflammatory bias in multiple sclerosis |
| Q37726647 | CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. |
| Q36946584 | CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells |
| Q28506176 | Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice |
| Q22253485 | Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation |
| Q34397047 | Chemokine expression and viral infection of the central nervous system: regulation of host defense and neuropathology |
| Q35896044 | Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis |
| Q37349685 | Chemokine receptor antagonists: overcoming developmental hurdles |
| Q37372802 | Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin |
| Q36981179 | Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection |
| Q34435582 | Chemokines and central nervous system disorders |
| Q34306643 | Chemokines and viral diseases of the central nervous system |
| Q33760195 | Chemokines as molecular targets for therapeutic intervention |
| Q34348557 | Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures. |
| Q89684473 | Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis |
| Q42476082 | Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis |
| Q41712468 | Cytokine-induced inflammation in the central nervous system revisited |
| Q35175775 | Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis |
| Q54209318 | Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice. |
| Q33846745 | Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus |
| Q93051902 | Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis |
| Q77419240 | Effect of the synthetic immunomodulator, linomide, on experimental models of thyroiditis |
| Q34041971 | Experimental autoimmune encephalomyelitis in the mouse |
| Q48290859 | Expression of nitric oxide synthase-2 in glia associated with CNS pathology. |
| Q24563395 | Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients |
| Q35543779 | Fine Tuning the Transcriptional Regulation of the CXCL1 Chemokine |
| Q37112554 | G protein-coupled receptors as therapeutic targets for multiple sclerosis |
| Q37634375 | Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned |
| Q34343628 | HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases |
| Q22010731 | Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis |
| Q40091331 | IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel. |
| Q54340434 | IL-17A induces MIP-1α expression in primary astrocytes via Src/MAPK/PI3K/NF-kB pathways: implications for multiple sclerosis. |
| Q28591681 | Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 |
| Q28585385 | Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice |
| Q37243469 | Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis |
| Q33775611 | Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro. |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q37586600 | Inflammation in epileptogenesis after traumatic brain injury. |
| Q40868682 | Inflammation in traumatic brain injury: role of cytokines and chemokines |
| Q36147149 | Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination |
| Q37040035 | Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug |
| Q36366372 | Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis |
| Q37378111 | Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q37183047 | Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis. |
| Q39888649 | MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling |
| Q74096662 | MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord |
| Q34009397 | Macrophage inflammatory protein 1alpha/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection |
| Q77953513 | Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1 |
| Q36368565 | Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. |
| Q37620006 | Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid |
| Q37308226 | Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis. |
| Q34878368 | MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). |
| Q36899339 | Monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1 |
| Q35208773 | Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis |
| Q36400419 | Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines |
| Q73581841 | Murine astrocytes express a functional chemokine receptor |
| Q24645165 | Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1 |
| Q34392185 | Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes |
| Q35087794 | Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition |
| Q52548644 | Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. |
| Q37383845 | Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model |
| Q35745707 | Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development |
| Q37364480 | Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis |
| Q42465251 | Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. |
| Q34630302 | Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors |
| Q39522424 | Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. |
| Q36001202 | Regulatory functions of CD8+CD28– T cells in an autoimmune disease model |
| Q33760189 | Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis |
| Q35022576 | Slit proteins, potential endogenous modulators of inflammation |
| Q35764734 | Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis |
| Q35825040 | Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. |
| Q74291450 | Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription |
| Q43103712 | The "window of susceptibility" for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines |
| Q74582183 | The CC chemokine MIP-1alpha induces a selective monocyte infiltration following intradermal injection into nonhuman primates |
| Q26773127 | The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases |
| Q36399022 | The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis |
| Q38899745 | The blood-brain barrier in Alzheimer's disease. |
| Q24337078 | The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization |
| Q33595360 | The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function |
| Q60311707 | The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells |
| Q37560782 | The multifaceted profile of activated microglia. |
| Q33496653 | Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice |
| Q36124510 | Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal |
| Q33713319 | Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein. |
| Q37780481 | Transgenic mouse models of multiple sclerosis |
| Q42983070 | Upregulation of expression of the chemokine receptor CCR5 by hydrogen peroxide in human monocytes |
| Q28345267 | Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice |
| Q79151474 | [Chemokine--possible new options for the treatment of multiple sclerosis] |
Search more.